SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-22-072381
Filing Date
2022-06-17
Accepted
2022-06-17 16:06:07
Documents
1
Period of Report
2022-06-14

Document Format Files

Seq Description Document Type Size
1 FORM 4/A tm2218810-1_4a.html 4/A  
1 FORM 4/A tm2218810-1_4a.xml 4/A 6501
  Complete submission text file 0001104659-22-072381.txt   7982
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2125 1ST AVENUE #2902 SEATTLE WA 98121-2121
Business Address
Ferguson Kenneth M. (Reporting) CIK: 0001934344 (see all company filings)

Type: 4/A | Act: 34 | File No.: 000-50626 | Film No.: 221023791